欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7296/001
药品名称Bortezomib Qilu
活性成分
    • BORTEZOMIB 2.5 mg/ml
剂型Solution for injection
上市许可持有人Qilu Pharma Spain S.L. Paseo Castellana 40 Planta 8 28046 Madrid Spain
参考成员国 - 产品名称Germany (DE)
Bortezomib Qilu 2.5 mg/ml Injektionslösung
互认成员国 - 产品名称
    • France (FR)
    • Spain (ES)
    • Italy (IT)
许可日期2023/08/24
最近更新日期2023/09/04
药物ATC编码
    • L01XG01 bortezomib
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase